Oxidative stress has a significant impact on TD, and more and more recent studies have found that some strong antioxidants, such as melatonin (MT) [11], vitamin E, VMAT2 inhibitor, and other antioxidants, have a significant easing effect on the clinical manifestations of TD [7]. Here, SLC18A2 is linked to thanatophoric dysplasia.